Clinical Investigation

Kidney International (1995) 48, 501–509; doi:10.1038/ki.1995.320

Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells

Mary S Hammes1, John C Lieske1, Shashi Pawar1, Benjamin H Spargo1 and F Gary Toback1

1Departments of Medicine and Pathology, The University of Chicago, Chicago, Illinois, USA

Correspondence: Dr Mary S Hammes, University of Chicago, Department of Medicine, MC 5100, 5841 South Maryland Avenue, Chicago, Illinois 60637-1463, USA.

Received 16 November 1994; Revised 4 March 1995; Accepted 6 March 1995.

Top

Abstract

Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Primary or secondary hyperoxaluria is associated with calcium oxalate nephrolithiasis, interstitial fibrosis and progressive renal insufficiency. Monolayer cultures of nontransformed monkey kidney epithelial cells (BSC-1 line) and calcium oxalate monohydrate (COM) crystals were used as a model system to study cell responses to crystal interactions that might occur in the nephrons of patients during periods of hyperoxaluria. To determine if COM crystals signal a change in gene expression, Northern blots were prepared from total renal cellular RNA after the cells were exposed to crystals. The immediate early genes c-myc, EGR-1, and Nur-77 were induced at one hour. At two to six hours stimulated expression of the genes encoding plasminogen activator inhibitor (PAI-1) and platelet-derived growth factor (PDGF)-A chain was detected, but constitutive expression of urokinase-type plasminogen activator (u-PA) was not altered. Expression of connective tissue growth factor (CTGF) was induced at one hour and persisted up to 24 hours. The stimulation of gene expression by COM crystals was relatively crystal- and renal cell-type specific. Thus the interaction of kidney epithelial cells with COM crystals alters expression of genes that encode three classes of proteins: transcriptional activators, a regulator of extracellular matrix (ECM), and growth factors. Activation of PAI-1 gene expression without a change in u-PA favors accumulation of ECM proteins, as does increased expression of PDGF and CTGF which can also stimulate fibroblast proliferation in a paracrine manner. These results suggest that COM crystal-mediated stimulation of specific genes in renal tubular cells may contribute to the development of interstitial fibrosis in hyperoxaluric states.

Top

References

  1. Brett F, Kealy WF, Murnaghan D, Hogan JM: Primary hyperoxaluria-a case report. Irish J Med Sci 159:78–79, 1990
  2. Canos HJ, Hogg GA, Jeffery JR: Oxalate nephropathy due to gastrointestinal disorders. Can Med Assoc J 124:729–733, 1981 | PubMed | ChemPort |
  3. Cryer PE, Garber AJ, Hoffstein P, Lucas B, Wise L: Renal failure after small intestinal bypass for obesity. Arch Intern Med 135:1610–1612, 1975
  4. Das S, Joseph B, Dick AL: Renal failure owing to oxalate nephrosis after jejunoileal bypass. J Urol 121:506–509, 1979
  5. Gelbart DR, Brewer LL, Fajardo LF, Weinstein AB: Oxalosis and chronic renal failure after intestinal bypass. Arch Intern Med 137:239–243, 1977 | Article | PubMed | ISI | ChemPort |
  6. Koten JW, Van Gastel C, Dorhoutmees EJ, Holleman LWJ, Schuiling RD: Two cases of primary oxalosis. J Clin Pathol 18:223–229, 1965
  7. Mandel I, Krauss E, Millan JC: Oxalate-induced acute renal failure in Crohn's disease. Am J Med 69:628–632, 1980
  8. Salyer WR, Keren D: Oxalosis as a complication of chronic renal failure. Kidney Int 4:61–66, 1973 | PubMed |
  9. Saxon A, Busch GJ, Merril JP, Franco V, Wilson RE: Renal transplantation in primary hyperoxaluria. Arch Intern Med 133:464–467, 1974 | Article | PubMed | ISI | ChemPort |
  10. Fransino JA, Vanamee P, Rosen PP: Renal oxalosis and azotemia after methoxyflurane anesthesia. J Engl J Med 283:676–679, 1970
  11. Dezegher FE, Wolff ED, Heijen AJ, Sukhai RN: Oxalosis in infancy. Clin Nephrol 22:114–120, 1984
  12. Ehlers SM, Posalaky Z, Strate RG, Quattlebaum FW: Acute reversible renal failure following jejunoileal bypass for morbid obesity: a clinical and pathologic (EM) study of a case. Surgery 82:629–634, 1977 | PubMed | ChemPort |
  13. Warton R, D'Agati VD, Magun AM, Whitlock R, Kunis CL, Appel GB: Acute deterioration of renal function associated with enteric hyperoxaluria. Clin Nephrol 34:116–121, 1990
  14. Drenick EJ, Stanley TM, Border WA, Zawada ET, Dornfield LP, Upham T, Lach F: Renal damage with intestinal bypass. Ann Intern Med 89:594–599, 1978 | PubMed |
  15. Lieske JC, Spargo BH, Toback FG: Endocytosis of calcium oxalate crystals and proliferation of renal tubular cells in a patient with type I primary hyperoxaluria. J Urol 148:1517–1519, 1992 | PubMed | ISI | ChemPort |
  16. Stauffer M: Oxalosis. Report of a case, with a review of the literature and discussion of the pathogenesis. N Engl J Med 263:386–390, 1960
  17. Lieske JC, Walsh-Reitz MM, Toback FG: Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262:F662–F630, 1992
  18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987 | Article | PubMed | ISI | ChemPort |
  19. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13, 1983 | Article | PubMed | ISI | ChemPort |
  20. Wahl GM, Stern M, Stark GE: Efficient transfer of large DNA fragments from agarose gels to diazobenzloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci USA 76:3683–3687, 1979 | Article | PubMed | ChemPort |
  21. Hanks SK, Armour R, Baldwin JH, Maldonado F, Spiess J, Holley RW: Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from nucleotide sequence of the cDNA. Proc Natl Acad Sci USA 85:79–82, 1988
  22. Fanger H, Esparza A: Crystals of calcium oxalate in kidneys in uremia. Am J Clin Pathol 41:597–603, 1964
  23. Bennington JL, Haber SL, Smith JV, Warner NE: Crystals of calcium oxalate in the kidney. Am J Clin Pathol 41:8–14, 1964
  24. Nakai A, Kartha S, Sakurai A, Toback FG, Degroot LJ: A human early response gene homologous to murine nur77 and rat NGFI-B, and related to the nuclear receptor superfamily. Mol Endocrinol 4:1438–1443, 1990 | PubMed | ISI | ChemPort |
  25. Sukhatme VP, Kartha S, Toback FG, Taub R, Hoover RG, Tsai-Morris CH: A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1:343–355, 1987 | PubMed | ISI | ChemPort |
  26. Studzinski GP: Oncogenes, growth and the cell cycle: An overview. Cell Tissue Kinetics 22:405–424, 1989
  27. Ginsberg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielson L, Dano K, Lebo RV, Gelehrter: cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 78:1673–1680, 1986 | PubMed | ISI | ChemPort |
  28. Verde P, Stoppelli MP, Galaffi P, Di Nocera P, Blasi F: Identification and primary sequence of an unspliced human urokinase poly (A)+ RNA. Proc Natl Acad Sci USA 81:4727–4731, 1984 | Article | PubMed | ChemPort |
  29. Betsholtz C, Johnsson A, Heldin CH, Westermark B, Lind P, Urdea MS, Eddy R, Shows TB, Philpott K, Mellor AL, Knott TJ, Scott J: cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumor cell lines. Nature (London) 320:695–699, 1986 | Article | PubMed | ISI | ChemPort |
  30. Devare SG, Reddy EP, Law JD, Robbins KC, Aaronson SA: Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequence encode the transforming gene product p28sis. Proc Natl Acad Sci USA 80:731–735, 1983 | PubMed | ChemPort |
  31. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114:1285–1294, 1993
  32. Riese RJ, Riese JW, Kleinman JG, Wiessner JH, Mandel GS, Mandel NS: Specificity in calcium oxalate adherence to papillary epithelial cells in culture. Am J Physiol 255:F1025–F1032, 1988 | PubMed | ISI | ChemPort |
  33. Riese RJ, Mandel NS, Wiessner JH, Mandel GS, Becker CG, Kleinman JG: Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am J Physiol 262:F177–F184, 1982
  34. Lieske JC, Swift H, Martin T, Patterson B, Toback FG: Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci USA 91:6987–6991, 1994 | PubMed | ChemPort |
  35. Lieske JC, Toback FG: Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. Am J Physiol 264:F800–F807, 1993 | PubMed | ISI | ChemPort |
  36. Lieske JC, Leonard R, Toback FG: Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604–F612, 1995 | PubMed | ISI | ChemPort |
  37. Cheung HS, Mitchell PG, Pledger WJ: Induction of expression of c-fos and c-myc protooncogenes by basic calcium phosphate crystals: Effect of beta-interferon. Cancer Res 49:134–138, 1989
  38. Cheung HS, McCarty DJ: Mitogenesis induced by calcium-containing crystals. Role of intracellular dissolution. Exp Cell Res 157:63–70, 1985
  39. Mitchell PC, Pledger WJ, Cheung HS: Molecular mechanisms of basic calcium phosphate crystal-induced mitogenesis. J Biol Chem 264:14071–14077, 1989
  40. Cheung HS, Story MT, McCarty J: Mitogenic effect of hydroxy-apatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthr Rheum 27:668–674, 1984
  41. Roberge CJ, Grassi J, Medicis D, Frobert Y, Lussier A, Naccache PH, Poubelle PE: Crystal-neutrophil interaction leads to interleukin-1 synthesis. Agents Actions 34:38–41, 1991
  42. Guerne P-A, Terkeltaub R, Zuraw B, Lotz M: Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthr Rheum 32:1443–1452, 1989
  43. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K: Monocyte-derived neutrophil chemotactic factor interleukin-8 is a potential mediator of crystal-induced inflammation. Arthr Rheum 34:894–903, 1991
  44. Tomooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42:1462–1469, 1992 | PubMed | ISI | ChemPort |
  45. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 318:1657–1666, 1988 | PubMed | ISI | ChemPort |
  46. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN: Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 68:1–19, 1990 | Article | PubMed | ISI | ChemPort |
  47. Ruterford RB, Ross R: Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol 69:196–203, 1976
  48. Grotendorst GR: Alteration of the chemotactic response of NIH/3T3 cells to PDGF by growth factors, transformation, and tumor promoters. Cell 36:279–285, 1984 | Article | PubMed | ChemPort |
  49. Narayanan AS, Page RC: Biosynthesis and regulation of type V collagen in diploid human fibroblasts. J Biol Chem 258:11694–11699, 1983 | PubMed | ChemPort |
  50. Kartha S, Bradham DM, Grotendorst GR, Toback FG: Kidney epithelial cells express c-sis protooncogene and secrete PDGF-like protein. Am J Physiol 255:F800–F806, 1988 | PubMed | ISI | ChemPort |
  51. Williams HE: Oxalic acid and the hyperoxaluric syndromes. Kidney Int 13:410–417, 1978
  52. Khan SR, Finlayson B, Hackett RL: Experimental calcium oxalate nephrolithiasis in the rat. Am J Pathol 107:59–69, 1982 | PubMed | ISI | ChemPort |
  53. Khan SR, Hackett RL: Retention of calcium oxalate in renal tubules. Scan Microsc 5:707–712, 1991
  54. Khan SR, Shevock PN, Hackett RL: Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226–230, 1992 | PubMed | ISI | ChemPort |

Extra navigation

.
ADVERTISEMENT